Stryker Reconstructive Business Sales Drop 1.1%

Stryker has reported $781 million in quarterly sales for its reconstructive business line, down 1.1 percent compared to the same quarter last year.

Advertisement

Although the medical device company saw higher unit volumes, these gains were offset by unfavorable changes in price and foreign currency exchange rates. Stryker saw an overall sales gain of 1 percent totaling $2.1 billion for this quarter.

More Articles on Orthopedic Devices:

Johnson & Johnson Worldwide Medical Device, Diagnostics Sales Reach $7.1B

Brian McCollum to Lead Orthofix Spine Global Business Unit

Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.